Heterogeneity in PD-L1 expression between primary and metastatic lymph nodes: a predictor of EGFR-TKI therapy response in non-small cell lung cancer.
Yaohua HuYidan ZhangYou LuYingqi XuJianlin XuHua ZhongLei ChengRunbo ZhongPublished in: Respiratory research (2024)
This retrospective study was approved by the Ethics Committee of Shanghai Chest Hospital (ID: IS23060) and performed following the Helsinki Declaration of 1964 (revised 2008).
Keyphrases
- lymph node
- small cell lung cancer
- tyrosine kinase
- epidermal growth factor receptor
- public health
- squamous cell carcinoma
- advanced non small cell lung cancer
- single cell
- healthcare
- big data
- acute care
- adverse drug
- sentinel lymph node
- neoadjuvant chemotherapy
- drug administration
- machine learning
- stem cells
- emergency department
- chronic myeloid leukemia
- early stage
- mesenchymal stem cells
- bone marrow
- cell therapy
- artificial intelligence
- smoking cessation
- deep learning
- drug induced